Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

International projects source: SICRIS

Inhibitors of angiogenesis: design, synthesis and biological exploitation (ANGIOKEM)

Edit
Researchers (1)
no. Code Name and surname Research area Role Period No. of publications
1.  01463  PhD Danijel Kikelj  Pharmacy  Head  2007 - 2011  566 
Organisations (1)
no. Code Research organisation City Registration number No. of publications
1.  0787  University of Ljubljana, Faculty of Pharmacy  Ljubljana  1626973  17,186 
Abstract
Excessive or insufficient angiogenesis (new blood vessel formation) is connected with many human diseases, cancer included. For effective disease intervention, interdisciplinary approach in the research is necessary. This COST Action focuses on networking of interdisciplinary oriented chemistry and biology researchers who are actively involved in rationale designing and development of small organic compounds with anti-angiogenic properties. Exchanges of information and presentations of experiences and skills from chemical and biological research will be performed for effective introduction, exploitation and improvement of modern methods for development of new angiogenic inhibitors. Meetings, short-term scientific missions, workshops, training schools and conference will ensure the expansion of effective cooperation in the development of new drug candidates. Keywords: Inhibition of neovascularisation; lead compounds and drug design; treatment of cancer and other diseases; in silico predictions; multivalency in organic synthesis and biology
Confirmation required
Views history
Favourite